1.. Introduction
================

Our previous chemical examination of soft corals of the genus *Sinularia* led to the isolation and identification of various oxygenated cembrane-type metabolites \[[@b1-marinedrugs-09-00944]--[@b5-marinedrugs-09-00944]\]. Some of these metabolites exhibit anti-inflammatory activity \[[@b2-marinedrugs-09-00944]--[@b4-marinedrugs-09-00944]\] and/or cytotoxicity to the growth of some cancer cell lines \[[@b1-marinedrugs-09-00944]\]. Our ongoing research to discover bioactive metabolites from the soft coral *Sinularia triangular* (Tixier-Durivault, 1970; family Alcyoniidae) ([Figure 1](#f1-marinedrugs-09-00944){ref-type="fig"}) led to the isolation of two new cembrane-based diterpenoids, triangulenes A (**1**) and B (**2**), along with three known metabolites, sinularin (**3**) \[[@b6-marinedrugs-09-00944]\], dihydrosinularin (**4**) \[[@b6-marinedrugs-09-00944]\], and (−)14-deoxycrassin (**5**) \[[@b7-marinedrugs-09-00944]\]. The structures of **1** and **2** were established by extensive spectroscopic analysis, including 2D NMR spectroscopy. The cytotoxicity of **1**--**5** to the human tumor cell lines CCRF-CEM (T-cell acute lymphoblastic leukemia) and DLD-1 (colon adenocarcinoma) was studied, and the ability of **1**--**5** to inhibit the expression of the pro-inflammatory iNOS (inducible nitric oxide synthase) and COX-2 (cyclooxygenase-2) proteins in lipopolysaccharide (LPS)--stimulated RAW264.7 macrophage cells was also evaluated.

2.. Results and Discussion
==========================

Frozen samples of *S. triangular* were extracted with EtOAc. The dry EtOAc extracts were fractionated by silica gel gravity column chromatography, and the eluted fractions were further purified by HPLC to yield cembranoids **1**--**5** ([Figure 2](#f2-marinedrugs-09-00944){ref-type="fig"}).

The HRESIMS spectrum of triangulene A (**1**) contained a molecular ion peak consistent with the molecular formula C~20~H~32~O~2~, indicating the molecule has five double-bond equivalent. A UV absorption maxima at 240 nm (log*ɛ* = 4.0) was attributed to double bond conjugation. The IR spectrum of **1** revealed the presence of a carbonyl functionality (ν~max~ = 1703 cm^−1^). The ^13^C NMR data of **1** showed the presence of 20 carbons ([Table 1](#t1-marinedrugs-09-00944){ref-type="table"}): five methyls, six sp^3^ methylenes, three sp^3^ methines (including an oxygenated carbon at δ 62.7), two sp^2^ methines, and four quaternary carbons (including an oxygenated carbon at δ 61.5, two olefinic carbons with resonances at δ 148.3 and δ 129.3, and a keto-carbonyl at δ 209.8). The ^1^H NMR data revealed the presence of two olefinic methine protons as doublets at δ 6.15 and δ 6.06. A proton signal at δ 2.71 (1H, dd, *J* = 8.4, 4.0 Hz) that correlated with a carbon signal at δ 62.7 in the HMQC spectrum of **1** was attributed to the proton of a trisubstituted epoxide. The gross planar structure of **1** was determined by detailed analysis of its 1D and 2D NMR spectra. From the ^1^H--^1^H COSY correlations ([Figure 3](#f3-marinedrugs-09-00944){ref-type="fig"}), it was possible to establish five partial structures of consecutive proton spin systems extending from H-2 to H-3; H-8 to H~3~-19; H~2~-9 to H-11; H~2~-13 to H~2~-14; and H-15 to H~3~-16 and H~3~-17. The following key HMBC correlations permitted connection of the carbon skeleton: H-2 to C-1, C-14, and C-15; H-3 to C-5; H-5 to C-4 and C-6 (carbonyl carbon); H-7 to C-6, C-8, and C-9; H-13 to C-11 and C-12; H~3~-16 and H~3~-17 to C-1 and C-15; H~3~-18 to C-3, C-4, and C-5; H~3~-19 to C-7, C-8, and C-9; and H~3~-20 to C-11, C-12, and C-13. Thus, **1** was found to possess a tetrasubstituted diene at C-1/C-2 and C-3/C-4, a ketone group at C-6, and a trisubstituted epoxide at C-11/C-12. The above results indicate that **1** possessed the same molecular framework as known cembranoids **6** and **7** ([Figure 4](#f4-marinedrugs-09-00944){ref-type="fig"}), which were isolated previously from octocorals *Eunicea tourniforti* \[[@b8-marinedrugs-09-00944]\] and *Eunicea* sp. \[[@b9-marinedrugs-09-00944]\], respectively.

The relative configuration of **1** was determined from NOE correlations observed in the NOESY spectrum ([Figure 5](#f5-marinedrugs-09-00944){ref-type="fig"}). The NOE correlations between H-2 and methyl protons H~3~-16 and H~3~-18 and between H-3 and H~2~-5 indicated *E* configurations for the double bonds at C-1/C-2 and C-3/C-4. In addition, one proton of C-10 methylene (δ 1.92) was found to exhibit correlations with H-11 (δ 2.71, dd, *J* = 8.4, 4.0 Hz) and H~3~-19 (δ 0.93, d, *J* = 6.8 Hz), indicating that these protons were situated on the same face; they were assigned as α protons, as C-20 methyl was β-oriented at C-12, which were verified by the absence of correlation between H-11 and H~3~-20. Furthermore, H~3~-20 correlated with protons of C-10 (δ 1.92 and 1.14) and C-14 (δ 2.37 and 2.28) methylenes, respectively. Consideration of molecular models found that H~3~-20 was reasonably close to H~2~-10 and H~2~-14 when H~3~-20 was β-oriented. Based on the above findings, the structure of **1**, including its relative configuration was established, and the chiral centers for **1** were assigned as 8*S*\*, 11*S*\*, and 12*S*\*. Furthermore, the chemical shifts of **1** were shifted downfield at C-7 (Δ*δ~C~* +1.7 ppm) and C-8 (Δ*δ~C~* +2.5 ppm) and upfield at C-19 (Δ*δ~C~* −0.8 ppm) relative to the corresponding chemical shifts of **7**. On the basis of the above findings, we determined the relative structure of **1**, which was determined to be the C-8 epimer of **7**.

Triangulene B (**2**) had the same molecular formula (C~20~H~32~O~2~) as **1**, as indicated by HRESIMS and NMR spectra ([Table 1](#t1-marinedrugs-09-00944){ref-type="table"}). Comparison of the ^1^H and ^13^C NMR data of **2** with those of **1** revealed that the two compounds possessed similar structures. The trisubstituted double bonds at C-1/C-2 and C-3/C-4 of **2** had *Z* geometries, as indicated by NOE interactions ([Figure 5](#f5-marinedrugs-09-00944){ref-type="fig"}) between H-3 (δ 6.29) and H~3~-18 (δ 1.93) and between H-2 (δ 6.19) and H-5 (δ 3.90). After determining the structure of **2**, we discovered that its planar structure has been obtained previously as diterpenoid **8** from the octocoral *Eunicea* sp. \[[@b8-marinedrugs-09-00944]\]. Furthermore, we found that the NMR data for **2** were similar to those of **8**, except that C-7 and C-8 of **2** were shifted markedly downfield (Δδ~C~ +3.9 ppm and Δδ~C~ +3.6 ppm, respectively) relative to the corresponding carbons of **8**. Further analysis of other NOE interactions revealed that **1** and **2** possessed the same relative configurations at C-8, C-11, and C-12. Thus, the structure of **2** was established unambiguously.

Study of the cytotoxicity of diterpenoids **1**--**5** to human tumor cell lines CCRF-CEM and DLD-1 showed that **3** and **5** moderately inhibited the growth of the tested cell lines (the ED~50~ values were 26.0 and 37.1 μM for **3** and 29.8 and 32.2 μM for **5** for CCRF-CEM and DLD-1, respectively). The *in vitro* anti-inflammatory effects of **1**--**5** were also tested. The inhibition of LPS-stimulated upregulation of the pro-inflammatory proteins iNOS and COX-2 in RAW264.7 macrophage cells was measured by immunoblot analysis. At a concentration of 10 μm, **3**--**5** reduced the levels of the iNOS protein to 1.2 ± 0.3%, 5.1 ± 1.6%, and 0.9 ± 0.7%, respectively, of the levels in control cells stimulated with LPS alone (set at 100%). At the same concentration, **4** and **5** markedly reduced the levels of COX-2 to 24.9 ± 7.4% and 5.9 ± 1.0%, respectively, relative to controls ([Figure 6](#f6-marinedrugs-09-00944){ref-type="fig"}).

3.. Experimental Section
========================

3.1.. General Experimental Procedures
-------------------------------------

Melting points were measured on Fargo apparatus and are uncorrected. Optical rotation values were measured with a Jasco P-1010 digital polarimeter. Ultraviolet spectra were recorded on a Jasco V-650 spectrophotometer. IR spectra were obtained with a Varian Digilab FTS 1000 FT-IR spectrophotometer. NMR spectra were recorded with a Varian Mercury Plus 400 FT-NMR, at 400 MHz for ^1^H NMR and 100 MHz for ^13^C NMR, in CDCl~3~. ESIMS and HRESIMS data were recorded with a Bruker APEX II mass spectrometer. Silica gel 60 (230--400 mesh; Merck, Darmstadt, Germany) was used for column chromatography. Gravity column chromatography was performed on silica gel (230--400 mesh; Merck). TLC was carried out on precoated Kieselgel 60 F254 (0.2 mm; Merck), and spots were visualized by spraying with 10% H~2~SO~4~ solution followed by heating. HPLC was performed on a system comprising a Hitachi L-7100 pump, a Hitachi photodiode array detector L-7455, and a Rheodyne 7725 injection port. A semi-preparative reverse-phase column (Hibar 250 × 10 mm, LiChrospher 100 RP-18e, 5 μm, Merck) and a preparative normal-phase column (Hibar 250 × 21 mm, Si-60 column, 7 μm, Merck) were used for HPLC.

3.2.. Animal Material
---------------------

The marine soft coral *S. triangular* (specimen No. 200807-15) was collected by scuba divers at a depth of around 10 m off the coast of Taitung County, Taiwan, in July 2008, and the samples were frozen immediately after collection. A voucher sample was deposited at the Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Taiwan.

3.3.. Extraction and Separation
-------------------------------

The frozen bodies of *S. triangular* (1.2 kg, wet weight) were minced and exhaustively extracted with EtOAc (1 L × 5). The combined EtOAc extracts (15.5 g) were subjected to silica gel column chromatography with elution by EtOAc in *n*-hexane (0--100%, stepwise) followed by 100% acetone; and the fractions were pooled on the basis of TLC analysis to yield 17 fractions. Fraction 8 (265 mg), which eluted with *n*-hexane--EtOAc (10:1), was subjected to silica gel column chromatography with gradient elution (*n*-hexane--acetone, 12:1 to 6:1) to afford five subfractions (A1--A5). Subfraction A2 (20 mg) was subjected to reverse-phase HPLC with MeOH--H~2~O (5:1) elution to afford **1** (2.5 mg) and **2** (2.0 mg). Subfraction A3 (90 mg) was subjected to normal-phase HPLC using *n*-hexane--acetone (10:1) to afford **5** (50.3 mg). Fraction 11 (160 mg), which eluted with *n*-hexane--EtOAc (5:1), was subjected to silica gel column chromatography with gradient elution (*n*-hexane--acetone, 8:1 to 5:1) to yield six subfractions (B1--B6). Subfraction B3 was subjected to normal-phase HPLC with *n*-hexane--acetone (7:1) elution to afford **3** (20.5 mg) and **4** (10.8 mg).

Triangulene A (**1**): colorless oil; \[α\]^25^~D~ +70.8 (*c* 0.5, CHCl~3~); IR (neat) *v*~max~ 2961, 2928, 1703, 1456, 1385, and 1261 cm^−1^; UV (MeOH) λ~max~ 240 (log ɛ = 4.0); ^13^C and ^1^H NMR data, see [Table 1](#t1-marinedrugs-09-00944){ref-type="table"}; ESIMS *m/z* 327 \[M + Na\]^+^; HRESIMS *m/z* 327.2302 \[M + Na\]^+^ (calcd for C~20~H~32~O~2~Na, 327.2300).

Triangulene B (**2**): colorless oil; \[α\]^25^~D~ +50.6 (*c* 0.5, CHCl~3~); IR (neat) *v*~max~ 2959, 2928, 1709, 1460, and 1385 cm^−1^; UV (MeOH) λ~max~ 239 (log ɛ = 3.8); ^13^C and ^1^H NMR data, see [Table 1](#t1-marinedrugs-09-00944){ref-type="table"}; ESIMS *m/z* 327 \[M + Na\]^+^; HRESIMS *m/z* 327.2301 \[M + Na\]^+^ (calcd for C~20~H~32~O~2~Na, 327.2300).

Sinularin (**3**): white powder; mp 151--153 °C; \[α\]^25^~D~ −120 (*c* 0.5, CHCl~3~); ESIMS *m/z* 357 \[M + Na\]^+^ \[[@b6-marinedrugs-09-00944]\].

Dihydrosinularin (**4**): white powder; mp 116--118 °C; \[α\]^25^~D~ --42 (*c* 0.3, CHCl~3~); ESIMS *m/z* 359 \[M + Na\]^+^ \[[@b6-marinedrugs-09-00944]\].

(−)14-Deoxycrassin (**5**): colorless oil; \[α\]^25^~D~ −15 (*c* 1.0, CHCl~3~); ESIMS *m/z* 341 \[M + Na\]^+^ \[[@b7-marinedrugs-09-00944]\].

3.4.. Cytotoxicity Testing
--------------------------

The cytotoxicity of **1**--**5** to CCRF-CEM and DLD-1 tumor cells was evaluated by means of the tetrazolium-based colorimetric assay \[[@b10-marinedrugs-09-00944],[@b11-marinedrugs-09-00944]\]. As a positive control, we employed doxorubicin, which exhibited cytotoxicity to CCRF-CEM and DLD-1 cells with ED~50~ values of 0.57 and 0.25 μm, respectively.

3.5.. *In Vitro* Anti-Inflammatory Assay
----------------------------------------

A macrophage (RAW264.7) cell line was purchased from ATCC. We measured the *in vitro* anti-inflammatory activities of **1**--**5** by examining the inhibition of LPS-simulated upregulation of the iNOS (inducible nitric oxide synthetase) and COX-2 (cyclooxygenase-2) proteins in macrophages using western blotting analysis \[[@b12-marinedrugs-09-00944],[@b13-marinedrugs-09-00944]\].
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![Immunoblot analysis of the effects of **1**--**5** (10 μM) on the expression of the iNOS and COX-2 proteins of RAW264.7 macrophage cells: (**A**) Immunoblots of iNOS and β-actin and (**B**) immunoblots of COX-2 and β-actin. The relative intensity for the cells stimulated with LPS alone was set at 100%. Band intensities were quantified by densitometry and are indicated as percentages relative to the intensities for the LPS-stimulated cells. Western blotting with β-actin was performed to verify that equivalent amounts of protein were loaded in each lane. Values represent mean ± SEM (*n* = 6). \*Significantly different from the values for cells stimulated with LPS alone (\**P* \< 0.05). *^a^*Stimulated with LPS alone; *^b^*stimulated with LPS in the presence of **1**--**5**.](marinedrugs-09-00944f6){#f6-marinedrugs-09-00944}

###### 

^1^H and ^13^C NMR data for **1** and **2**.

       **1**                          **2**                                         
  ---- ------------------------------ -------------- ------------------------------ --------------
  1                                   148.3 (C)                                     146.7 (C)
  2    6.06 d (10.8)                  118.2 (CH)     6.19 d (10.8)                  118.7 (CH)
  3    6.15 d (10.8)                  125.7 (CH)     6.29 d (10.8)                  124.4 (CH)
  4                                   129.3 (C)                                     130.5 (C)
  5    3.20 d (13.6); 3.06 d (13.6)   54.7 (CH~2~)   3.90 d (13.6); 2.70 d (13.6)   48.9 (CH~2~)
  6                                   209.8 (C)                                     208.0 (C)
  7    2.54 dd (13.2, 8.4); 2.17 m    51.2 (CH~2~)   2.52 m; 2.12 m                 52.4 (CH~2~)
  8    2.03 m                         31.2 (CH)      1.83 m                         32.0 (CH)
  9    1.48 m; 1.18 m                 33.1 (CH~2~)   1.31 m; 1.14 m                 33.3 (CH~2~)
  10   1.92 m; 1.14 m                 26.4 (CH~2~)   1.88 m; 1.09 m                 26.4 (CH~2~)
  11   2.71 dd (8.4, 4.0)             62.7 (CH)      2.49 m                         64.4 (CH)
  12                                  61.5 (C)                                      60.6 (C)
  13   2.15 m; 1.32 m                 36.7 (CH~2~)   2.12 m; 1.36 m                 36.7 (CH~2~)
  14   2.37 m; 2.28 m                 25.9 (CH~2~)   2.73 m; 2.12 m                 25.7 (CH~2~)
  15   2.35 m                         32.2 (CH)      2.35 m                         30.8 (CH)
  16   1.06 d (7.2)                   22.6 (CH~3~)   1.18 d (6.8)                   20.6 (CH~3~)
  17   1.08 d (7.6)                   22.1 (CH~3~)   1.02 d (6.8)                   23.4 (CH~3~)
  18   1.89 s                         18.2 (CH~3~)   1.93 s                         25.1 (CH~3~)
  19   0.93 d (6.8)                   19.5 (CH~3~)   0.85 d (6.4)                   19.2 (CH~3~)
  20   1.20 s                         17.6 (CH~3~)   1.23 s                         16.3 (CH~3~)

Spectra were recorded at 400 MHz in CDCl~3~; *J* values (Hz) are given in parentheses;

spectra were recorded at 100 MHz in CDCl~3~; attached protons were deduced by DEPT experiments.
